Protagenic Therapeutics
Pre-clinicalDevelops neuropeptide-based therapeutics for stress-related disorders and depression.
Founded
2015
Focus
RNA & Gene Therapy
About
Develops neuropeptide-based therapeutics for stress-related disorders and depression.
Funding History
2Total raised: $12.5M
Series A$10MUndisclosedMar 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile